Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
898 studies found for:    Uterine Cancer: Clinical Trials
Show Display Options
Rank Status Study
1 Completed Uterine Papillary Serous Cancer (UPSC) Trial
Condition: Uterine Cancer
Intervention: Drug: Paclitaxel, Carboplatin
2 Completed A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide in Patients With MMT of the Uterus
Condition: Uterine Cancer
Interventions: Drug: Ifosfamide;   Procedure: Radiation Therapy
3 Completed Diet and Physical Activity in Uterine Cancer Survivors
Condition: Endometrial Neoplasms
Intervention: Behavioral: Shape-Up following cancer treatment
4 Terminated Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Uterine Cancer
Intervention: Drug: Paclitaxel, Cisplatin IP
5 Recruiting Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
Conditions: Stage IA Uterine Sarcoma;   Stage IB Uterine Sarcoma;   Stage IC Uterine Sarcoma;   Stage IIA Uterine Sarcoma;   Stage IIB Uterine Sarcoma;   Stage IIIA Uterine Sarcoma;   Stage IIIB Uterine Sarcoma;   Stage IIIC Uterine Sarcoma;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Radiation: intensity-modulated radiation therapy;   Other: laboratory biomarker analysis
6 Completed Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
Conditions: Endometrial Adenocarcinoma;   Stage I Uterine Corpus Cancer;   Stage I Uterine Sarcoma;   Stage II Uterine Corpus Cancer;   Stage II Uterine Sarcoma
Interventions: Procedure: Laparoscopic Surgery;   Other: Quality-of-Life Assessment;   Procedure: Therapeutic Conventional Surgery
7 Completed Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
Conditions: Ovarian Neoplasms;   Uterine Neoplasms
Intervention: Drug: Topotecan and Taxotere
8 Terminated A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
Condition: Uterine Cancer
Intervention: Drug: Celecoxib
9 Recruiting Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
Conditions: Endometrial Serous Adenocarcinoma;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC1 Uterine Corpus Cancer;   Stage IIIC2 Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: 3-Dimensional Conformal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis
10 Recruiting Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen
Conditions: Breast Cancer;   Ovarian Cancer;   Cancer of the Uterus
Interventions: Drug: GDC-0032;   Drug: Tamoxifen
11 Active, not recruiting Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Conditions: Recurrent Cervical Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Uterine Corpus Sarcoma;   Stage I Uterine Corpus Cancer;   Stage I Uterine Sarcoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage II Uterine Corpus Cancer;   Stage II Uterine Sarcoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Uterine Corpus Cancer;   Stage III Uterine Sarcoma;   Stage IV Uterine Corpus Cancer;   Stage IV Uterine Sarcoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Other: Medical Chart Review;   Other: Questionnaire Administration
12 Completed Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
Conditions: Cancer of the Ovary Treated as 2nd Line Therapy;   Muellerian Mixed Tumours;   Tumours of the Uterus;   Cervical Cancers;   Non-Epithelial Ovarian Tumours
Intervention: Drug: Pegylated Liposomal Doxorubicin and Carboplatin
13 Completed A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Interventions: Drug: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Procedure: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Drug: Carboplatin and Paclitaxel and Radiation Therapy
14 Completed The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
Conditions: Cancer;   Breast Cancer;   Colon Cancer;   Cervical Cancer;   Uterine Cancer;   Ovarian Cancer
Intervention: Behavioral: Very low carbohydrate diet (approximately 20 grams per day)
15 Completed Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Radiation: radiation therapy
16 Unknown  Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -
Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas
Interventions: Drug: Pazopanib plus Gemcitabine;   Drug: Pazopanib
17 Completed Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers
Condition: Cervical Cancer
Interventions: Radiation: External radiotherapy + curietherapy;   Drug: Vistide;   Drug: Carboplatin
18 Completed Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: ifosfamide;   Drug: paclitaxel
19 Completed Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids
Conditions: Menorrhagia;   Leiomyoma;   Uterine Neoplasms
Interventions: Procedure: uterine artery embolization;   Procedure: hysterectomy
20 Completed Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Adult Solid Neoplasm;   Lung Carcinoid Tumor;   Recurrent Digestive System Neuroendocrine Tumor G1;   Recurrent Renal Cell Carcinoma;   Recurrent Uterine Corpus Sarcoma;   Stage III Renal Cell Cancer;   Stage IIIB Uterine Sarcoma;   Stage IIIC Uterine Sarcoma;   Stage IV Renal Cell Cancer;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Sarcoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Temsirolimus;   Biological: Trebananib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.